Inflammatory Rheumatic Diseases
All Therapeutic AreasTherapeutic Area

Inflammatory Rheumatic Diseases

Immunomodulatory MSC therapies for rheumatic conditions

Inflammatory rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and ankylosing spondylitis are chronic autoimmune conditions that cause inflammation of joints and connective tissue. MSC cells offer a unique therapeutic approach by directly acting on the dysfunctional immune system.

Clinical research shows that MSC cells effectively modulate the immune response by reducing the activity of auto-aggressive T-cells, promoting regulatory T-cells, and secreting anti-inflammatory mediators. This leads to reduced inflammation, pain relief, and slowed disease progression.

GaiaCell offers personalized MSC therapies for rheumatic diseases, tailored to each patient based on the type and severity of their condition. Our multidisciplinary approach involves collaboration with rheumatologists for optimal treatment outcomes.

Clinical Evidence

Clinical Evidence & Statistics

67%

Reduction in DAS28 disease activity score

12 mo

Remission duration after therapy

85%

Patients without serious side effects

Want to Learn More?

Fill out our questionnaire or contact us for a free consultation about MSC therapy options for your condition.